Metformin-An update

General Pharmacology

Volumn 24, Issue 6, 1993, Pages 1299-1309

  Bailey, Clifford J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; INSULIN; METFORMIN;

DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; LACTIC ACIDOSIS; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMAL; BLOOD GLUCOSE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; HUMAN; HYPOGLYCEMIC AGENTS; METFORMIN; SUPPORT, NON-U.S. GOV'T;

EID: 0027429210     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(93)90411-P     Document Type: Short Survey

References (70)

1. Metformin Revisited: Its Actions and Indications for Use
2. Biguanides and NIDDM
3. Hypoglycaemic, Antihyperglycaemic and Antidiabetic Drugs
4. Treatment-metformin
5. Effect of metformin on glucose metabolism in mouse soleus muscle.
6. Drugs inducing hypoglycemia
7. Effect of metformin on glucose metabolism in the splanchnic bed
8. Biguanide (Experimenteller Teil)
9. Sulphonylureas and metformin: efficacy and inadequacy
10. Influence of metformin on metabolic effect of insulin in human adipose tissue in vitro.
11. Mechanism of Metformin Action in Obese and Lean Noninsulin-Dependent Diabetic Subjects*
12. Metformin ameliorates extreme insulin resistance in a patient with anti-insulin receptor antibodies: description of insulin receptor and postreceptor effects in vivo and in vitro.
13. Mechanism of Action of Metformin: Insulin Receptor and Postreceptor Effects in Vitro and in Vivo*
14. Role of Lipid Oxidation in Pathogenesis of Insulin Resistance of Obesity and Type II Diabetes
15. Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats
16. The hypoglycaemic action of metformin
17. The effects of glucose, insulin and metformin on the order parameters of isolated red cell membranes
18. Metformin increases insulin-stimulated glucose transport in insulin-resistant human skeletal muscle.
19. Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients
20. Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas
21. Control of gluconeogenesis in rat liver cells. Flux control coefficients of the enzymes in the gluconeogenic pathway in the absence and presence of glucagon.
22. Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in Type 2 (non-insulin-dependent) diabetes mellitus
23. Structure of metformin hydrochloride
24. Pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle
25. Metformin: a review of its pharmacological properties and therapeutic use.
26. Biguanides and sulfonylureas as combination therapy in NIDDM.
27. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
28. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells.
29. Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes
30. Metformin does not increase energy expenditure of brown fat
31. The acute regulation of glucose absorption, transport and metabolism in rat small intestine by insulin in vivo.
32. Characterization of metformin transport system in NIH 3T3 cells
33. Stimulation of hexose transport by metformin in L6 muscle cells in culture
34. Signal Transduction and Protein Phosphorylation in the Regulation of Cellular Metabolism by Insulin
35. [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics].
36. Association of Metformin's Effect to Increase Insulin-Stimulated Glucose Transport With Potentiation of Insulin-Induced Translocation of Glucose Transporters From Intracellular Pool to Plasma Membrane in Rat Adipocytes
37. Metformin increases insulin sensitivity and basal glucose clearance in Type 2 (non-insulin dependent) diabetes mellitus
38. Dual effect of metformin in cultured rat hepatocytes: Potentiation of insulin action and prevention of insulin-induced resistance
39. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes
40. Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes
41. Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine.
42. Mammalian Facilitative Glucose Transporter Family: Structure and Molecular Regulation
43. Effect of metformin on peripheral insulin sensitivity in non insulin dependent diabetes mellitus.
44. Evidence that the flux control coefficient of the respiratory chain is high during gluconeogenesis from lactate in hepatocytes from starved rats. Implications for the hormonal control of gluconeogenesis and action of hypoglycaemic agents.
45. Metformin enhances certain insulin actions in cultured rat hepatoma cells
46. Direct effects of biguanides on glucose utilization in vitro
47. Erythrocyte glucose consumption in insulin-dependent diabetes: effect of metformin in vitro.
48. Combined metformin-sulfonylurea treatment of patients with noninsulin-dependent diabetes in fair to poor glycemic control.
49. Effect of chronic metformin treatment on hepatic and muscle glycogen metabolism in KK mice
50. Glucose and lipid metabolism in non-insulin-dependent diabetes
51. Glucose toxicity
52. Effect of metformin treatment on insulin action in diabetic rats: In vivo and in vitro correlations
53. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin.
54. On the mechanism of action of hypoglycaemia-producing biguanides
55. Biguanides: molecular mode of action
56. Guanidines and biguanides
57. Changes in hepatic and intestinal cholesterol regulatory enzymes
58. The insulin receptor
59. Pharmacology and mode of action of hypoglycaemic guanidine derivatives
60. Insulin and atheroma. 20-yr perspective
61. lc with basal insulin supplement, sulfonylurea or biguanide therapy in maturity-onset diabetes
62. Metformin Normalizes Nonoxidative Glucose Metabolism in Insulin-Resistant Normoglycemic First-Degree Relatives of Patients With NIDDM
63. Defective glucose uptake and storage in diabetic erythrocytes and its correction by metformin
64. Sites of metformin-stimulated glucose metabolism
65. Reconsideration of inhibitory effect of metformin on intestinal glucose absorption
66. Subcellular distribution of metformin in rat liver
67. Inhibition of hepatic gluconeogenesis by metformin
68. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients
69. Inhibition of Carbohydrate-Induced Hypertriglyceridemia by Metformin